DMD Celsis microsomes mean better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinal, C. J.
Right arrow Articles by Bend, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinal, C. J.
Right arrow Articles by Bend, J. R.

Vol. 26, Issue 7, 681-688, July 1998

Enantioselective, Mechanism-Based Inactivation of Guinea Pig Hepatic Cytochrome P450 by N-(alpha -Methylbenzyl)-1-Aminobenzotriazole

Christopher J. Sinal, Maurice Hirst, Christopher D. Webb, and John R. Bend

Department of Pharmacology and Toxicology, University of Western Ontario

N-Aralkylated derivatives of 1-aminobenzotriazole are well-established, mechanism-based inhibitors of cytochrome P450 (CYP or P450). In this study, the kinetics of inactivation of CYP2B-dependent 7-pentoxyresorufin O-depentylation (PROD) and CYP1A-dependent 7-ethoxyresorufin O-deethylation (EROD) activities by enantiomers of N-(alpha -methylbenzyl)-1-aminobenzotriazole (alpha MB) were compared. The racemic mixture (±)-alpha MB, as well as the enantiomers (-)-alpha MB and (+)-alpha MB, produced a time-, concentration-, and NADPH-dependent loss of PROD and EROD activity in hepatic microsomes from phenobarbital-treated guinea pigs. The rates of PROD inactivation by (-)-alpha MB were significantly faster than for (+)-alpha MB. Consistent with this, the derived maximal kinact was also significantly greater for (-)-alpha MB than for (+)-alpha MB (0.49 vs. 0.35 min-1). In contrast, the concentrations required for the half-maximal rate of inactivation (Ki) were equivalent for (-)-alpha MB and (+)-alpha MB, whereas the degree of competitive inhibition of PROD activity was greater for (+)-alpha MB. No significant differences were found among (-)-alpha MB, (+)-alpha MB, and (±)-alpha MB with respect to mechanism-based inactivation (kinact = 0.18, 0.16, and 0.17 min-1, respectively) or competitive inhibition of EROD activity. No differences were found for the maximal extent of PROD or EROD inhibition or the loss of spectral P450 after an extended 30-min incubation with the inhibitors. We conclude that mechanism-based inactivation of guinea pig CYP2B, but not CYP1A, isozymes by alpha MB occurs in a stereoselective manner, most likely as a result of a difference in the balance between metabolic activation and deactivation for the alpha MB enantiomers.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. Lu, S. B. Singh, B. A. Carr, Y. Fang, C. D. Xiang, T. H. Rushmore, A. D. Rodrigues, and M. Shou
Selective Inhibition of Dog Hepatic CYP2B11 and CYP3A12
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 518 - 528.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.